Results 201 to 210 of about 5,339,936 (244)

Comprehensive Analysis of CXCR4, JUNB, and PD-L1 Expression in Circulating Tumor Cells (CTCs) from Prostate Cancer Patients. [PDF]

Cells
Roumeliotou A, Strati A, Chamchougia F, Xagara A, Tserpeli V, Smilkou S, Lagopodi E, Christopoulou A, Kontopodis E, Drositis I, Androulakis N, Georgoulias V, Koinis F, Kotsakis A, Lianidou E, Kallergi G.   +15 more
europepmc   +1 more source

Investigating the Influence of Preoperative Trans Arterial Embolization (TAE) and Predictive Potential of Circulating Tumor Cells (CTCs) in Prognosis of Hepatocellular Carcinoma. [PDF]

J Clin Exp Hepatol
Patkar S, Shetty O, Vyas K, Vengurlekar V, Kamble V, Shetty N, Kulkarni S, Gala K, Ballal D, Patel P, Kansaria R, Chaudhari V, Goel M.   +12 more
europepmc   +1 more source

Development and validation of a multi-marker liquid bead array assay for the simultaneous detection of PIK3CA and ESR1 hotspot mutations in single circulating tumor cells (CTCs). [PDF]

Heliyon
Stergiopoulou D, Georgoulias V, Markou A, Lianidou E.   +3 more
europepmc   +1 more source

Evaluation of PD-L1 expression on circulating tumor cells (CTCs) in patients with advanced urothelial carcinoma (UC). [PDF]

Oncoimmunology, 2020
Bergmann S, Coym A, Ott L, Soave A, Rink M, Janning M, Stoupiec M, Coith C, Peine S, von Amsberg G, Pantel K, Riethdorf S.   +11 more
europepmc   +1 more source

Relationship of Ki-67 index in biopsies of metastatic breast cancer tissue and circulating tumor cells (CTCs) at the time of biopsy collection. [PDF]

Arch Gynecol Obstet
Deutsch TM, Fischer C, Riedel F, Haßdenteufel K, Michel LL, Sütterlin M, Riethdorf S, Pantel K, Wallwiener M, Schneeweiss A, Stefanovic S.   +10 more
europepmc   +1 more source

Label-free counting of affinity-enriched circulating tumor cells (CTCs) using a thermoplastic micro-Coulter counter (μCC). [PDF]

Analyst, 2020
Kong C, Hu M, Weerakoon-Ratnayake KM, Witek MA, Dathathreya K, Hupert ML, Soper SA.   +6 more
europepmc   +1 more source

Circulating tumor cells (CTCs) for the noninvasive monitoring and personalization of non-small cell lung cancer (NSCLC) therapies. [PDF]

J Thorac Dis, 2019
Pawlikowska P, Faugeroux V, Oulhen M, Aberlenc A, Tayoun T, Pailler E, Farace F.   +6 more
europepmc   +1 more source

Integrated Molecular and Phenotypic Profiling of Circulating Tumor Cells in Gastric Cancer: A Translational Perspective. [PDF]

FASEB Bioadv
Eskandarion MR, Eskandarieh S, Shakoori Farahani A, Ghanbari Mardasi F, Mahmoodzadeh H, Roudini K, Shahi F, Oghabian MA, Taher M, Shirkoohi R.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Detection of Circulating Tumor Cells (CTCs) in Patients with Testicular Germ Cell Tumors

2020
While the majority of patients with advanced testicular germ cell tumors (GCT) achieve complete responses after chemotherapy and if indicated after postchemotherapy resection of residual lesions, about 20% of patients have incomplete responses or show relapses.
Paulina, Nastały, Friedemann, Honecker, Klaus, Pantel, Sabine, Riethdorf   +3 more
  +5 more sources

Pathophysiology of Tumor Cell Release into the Circulation and Characterization of CTC

2019
The traditional model of metastatic progression postulates that the ability to form distant metastases is driven by random mutations in cells of the primary tumor.
Tilman, Todenhöfer, Klaus, Pantel, Arnulf, Stenzl, Stefan, Werner   +3 more
openaire   +2 more sources